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Abstract.
BACKGROUND: Gilles de la Tourette syndrome (GTS) is a chronic childhood-onset neuropsychiatric disorder with a significant
impact on patients’ health-related quality of life (HR-QOL). Cavanna et al. (Neurology 2008; 71: 1410–1416) deve- loped and
validated the first disease-specific HR-QOL assessment tool for adults with GTS (Gilles de la Tourette Syndrome-Quality of Life
Scale, GTS-QOL). This paper presents the translation, adaptation and validation of the GTS-QOL for young Italian patients with
GTS.
METHODS: A three-stage process involving 75 patients with GTS recruited through three Departments of Child and Adolescent
Neuropsychiatry in Italy led to the development of a 27-item instrument (Gilles de la Tourette Syndrome-Quality of Life Scale in
children and adolescents, C&A-GTS-QOL) for the assessment of HR-QOL through a clinician-rated interview for 6–12 year-olds
and a self-report questionnaire for 13–18 year-olds.
RESULTS:TheC&A-GTS-QOL demonstrated satisfactory scaling assumptions and acceptability. Internal consistency reliability
was high (Cronbach’s alpha > 0.7) and validity was supported by interscale correlations (range 0.4–0.7), principal-component
factor analysis and correlations with other rating scales and clinical variables.
CONCLUSIONS: The present version of the C&A-GTS-QOL is the first disease-specific HR-QOL tool for Italian young patients
with GTS, satisfying criteria for acceptability, reliability and validity.
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1. Introduction
Gilles de la Tourette syndrome (GTS) is a chron-
ic neuropsychiatric disorder characterised by multiple
motor tics and at least one vocal/phonic tic for the du-
ration of one year, with onset in childhood [1]. Tics
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are defined as sudden, rapid, recurrent, non-rhythmic,
stereotyped movements or vocalizations. Prevalence
rates show wide variability, but recent studies suggest
a prevalence in youths aged 5–18 of about 1%, with a
male:female ratio of 3:1 [2].
Although motor and phonic tics are the hallmark of
GTS, this condition has been progressively recognised
as a complex disorder associated with a wide spectrum
of behavioural problems. Around 90% of patients seen
in specialist clinics present with co-morbid behavioural
difficulties, ranging from complex tic-like symptoms
(self-injurious behaviours, non obscene socially inap-
propriate behaviours, copro-, echo- and paliphenom-
ena) to attention deficit hyperactivity disorder (AD-
HD), obsessive-compulsive disorder (OCD), mood dis-
orders, impulse control disorders and personality dis-
orders [3,4].
Tics are associated with significant impairment and
personal distress. Moreover, co-morbid behavioural
problems can lead to social difficulties and impulse
dyscontrol in young patients [5]. Both tics and GTS-
associated disorders (i.e. ADHD, OCD) are potentially
socially disabling and can bear a detrimental impact
on health-related quality of life (HR-QOL) [6–11]. A
recent study by Eddy et al. [10] showed that patients
without co-morbidities (“Pure-GTS”) presented with
lower impact in their quality of life than GTS subjects
with OCD and/or ADHD.
HR-QOL is emerging as a critical measure of clini-
cal outcome, as it takes into account the patient’s own
subjective view on the impact of the medical condition
on his overall well-being. Disease-specific HR-QOL
measures have been developed for several neurological
conditions, and the first disease-specific HR-QOL as-
sessment tool for adult patients with GTS (Gilles de la
Tourette Syndrome-Quality of Life Scale, GTS-QOL)
has recently been developed and validated [12].
We report the development and full validation of the
first disease-specificHR-QOL assessment tool translat-
ed and validated for Italian young patients with GTS:
the Gilles de la Tourette Syndrome-Quality of Life
Scale for children and adolescents (C&A-GTS-QOL).
2. Methods
The Italian version of C&A-GTS-QOL was deve-
loped in three stages. The study was approved by the
local Ethics Committee and written informed consent
was obtained from each subject prior to enrolment into
the development and validation protocols.
Initially, forward-backward procedure was applied
to translate the GTS-QOL [12] from English into Ital-
ian (Stage 1: scale translation). A professional trans-
lator translated the questionnaire into Italian (“forward
translation”) and this version was backward translat-
ed into English (“backward translation”) by two blind
professional translators The authors compared the two
translated versions with the original English version, to
yield the linguistic validation of the provisional ques-
tionnaire in Italian. In order to check the Italian popula-
tion’s understanding and interpretation of the translated
items, the questionnaire was pre-tested on 10 patients
with GTS (clinical sample). The results were discussed
between experts and patients. This process led to a new
Italian version of the GTS-QOL.
Secondly, this scale was adapted for children and
adolescents and the C&A-GTS-QOL was created
through the following steps (Stage 2: scale adaptation):
– Four clinicians with expertise in the management
of children and adolescents with GTS indepen-
dently suggested how to simplify and rephrase
items that they considered to be confusing for
youths, and how to change the context of items
referring to adult life (e.g. job) to fit with a child’s
routine (e.g. school).
– The experts’ opinions for each of the 27 items were
compared and discussed with young patients with
GTS and the questionnaire was modified accord-
ingly.
– The questionnaire was administered to 20 children
(through interview) and 20 adolescents (through
selfreport questionnaire) randomly selected from
a nonclinical sample (school population). The re-
cruited subjects were asked to comment on the
comprehensibility of the items and to put them into
their own words.
– Wording adjustments were made by the same ex-
pert clinicians.
– To identify any further confusing items or words,
the adjusted questionnaire was administered to 75
youths from a school population in both the inter-
view version (48 children) and self-report version
(27 adolescents). Items rated as confusing by over
2% of the total sample were reworded or replaced.
Thirdly, the psychometric properties of the C&A-
GTS-QOL were examined in an independent sample
of 75 young patients with GTS (60 males; age range:
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6.8–18.3 years) recruited during 2009–2010 (Stage 3:
scale evaluation). This sample was recruited from three
Italian specialist centres: the Child and Adolescent
Neuropsychiatry Unit at University of Insubria, Varese
(n = 21), the Department of Child Neuropsychiatry at
University of Catania (n = 30), and the Department
of Child Neuropsychiatry at University of Rome (n =
24). Participantswere aged 6–18 years, had no learning
disabilities (IQ< 70) or other neurological conditions,
and met DSM-IV-TR criteria for the diagnosis of GTS.
All participants were evaluated by neuropsychiatrists
with substantial expertise in management of GTS, who
performedneurological examination, clinical interview
and cognitive evaluation. The clinical interview in-
cluded the National Hospital Interview Schedule for
GTS (NHIS-TS), a detailed semi-structured interview
schedule which covers personal and family histories
and demographic details [13], and the Diagnostic Con-
fidence Index (DCI), which rates the lifetime likelihood
of having GTS [14]. The KIDDIE-SADS-PL, a semi-
structured diagnostic interview designed to assess cur-
rent and past episodes of psychopathology in children
and adolescents according to DSM-III-R and DSM-IV
criteria [15] was used to validate the NHIS-TS diagno-
sis of various GTS-associated disorders, such as ADHD
and OCD. The severity of tic symptoms was assessed
using the Yale Global Tic Severity Scale (YGTSS) [16]
whilst the severity of obsessive-compulsive symptoms
was rated using the Children’s Yale-Brown Obses-
sive Compulsive Scale (CY-BOCS) [17]. All partici-
pants were asked to complete a booklet which includ-
ed the C&A-GTS-QOL, the Child Depression Invento-
ry (CDI) [18] and the Multidimensional Anxiety Scale
for Children (MASC) [19]. The CDI is a 27-item self-
report instrument that assesses depression symptoms
in children and adolescents aged 7–17 years, while the
MASC is a 39-item self-report scale that robustly rep-
resents the factor structure of anxiety in children aged
8–18 years.
Standard statistical methods were used to assess the
psychometric properties of the C&A-GTS QOL. We
examined scaling assumptions (equivalence of item
response option frequency distributions, item mean
scores, item standard deviations, item-total correla-
tions, principal-component factor analysis); acceptabil-
ity (distributions of subscale total scores, floor and ceil-
ing effects); reliability (internal consistency reliabili-
ty: Cronbach’s alpha); and validity (interscale correla-
tions, convergent and discriminant validity, and group
differences validity). The convergent validity of the fi-
nal questionnairewas examined by measuring the asso-
Table 1
Demographic and clinical characteristics of the GTS sample partici-
pating in stage 3 (scale evaluation)
Characteristics Overall population
(n = 75)
Male gender, n (%) 60 (80.0)
Age (yr), mean (sd) 12.4 (3.2)
Age at onset of GTS (yr), mean (sd) 6.7 (2.4)
Duration of GTS (yr), mean (sd) 2.0 (2.0)
Age at diagnosis of GTS (yr), mean (sd) 10.3 (2.7)
‘Pure’ GTS, n (%) 33 (44.0)
Presence of OCD, n (%) 25 (33.3)
Presence of ADHD, n (%) 6 (8.0)
Presence of ADHD + OCD, n (%) 11 (14.7)
Presence of coprolalia, n (%) 18 (24.0)
Presence of copropraxia, n (%) 9 (12.0)
Presence of echolalia, n (%) 20 (26.7)
Presence of echopraxia, n (%) 5 (6.7)
Presence of palilalia, n (%) 11 (14.7)
Patients with pharmacotherapy, n (%) 40 (53.3)
DCI score, mean (sd) 85.6 (23.8)
YGTSS total score, mean (sd) 44.3 (20.5)
CY-BOCS total score, mean (sd) 11.4 (10.0)
CDI score, mean (sd) 9.5 (6.9)
MASC total score, mean (sd) 49.5 (10.2)
Abbreviations. GTS = Gilles de la Tourette Syndrome; OCD =
obsessive-compulsive disorder; ADHD = attention deficit hyperac-
tivity disorder; DCI = Diagnostic Confidence Index; YGTSS =
Yale Global Tic Severity Scale; CY-BOCS= Children’s Yale-Brown
Obsessive Compulsive Scale; CDI = Child Depression Inventory;
MASC = Multidimensional Anxiety Scale for Children.
ciation between C&A-GTS-QOL subscores and demo-
graphic and clinical variables, including age, disease
duration, ratings of tic severity (YGTSS scores), OCD
symptoms (CY-BOCS scores), depression (CDI), anx-
iety (MASC). Associations between scores were tested
with Spearman rank correlations because of the ordi-
nal nature of the scales. All statistical analyses were
performed using SPSS for Windows.
3. Results
The final C&A-GTS-QOL consisted of 27 items
and four subscales (psychological, physical, obsessive-
compulsive and cognitive) in two age-adjusted versions
(see Appendix). The first version is an interview to be
administered by a qualified clinician, for youths aged
6–12 years. The second is a self-administered ques-
tionnaire for adolescents aged 13–18 years. Each item
is rated across five response options: ‘Never’, ‘Rarely’,
‘Sometimes’, ‘Often’, ‘Always’.
The C&A-GTS-QOL was evaluated with respect to
scaling assumptions, acceptability, reliability and va-
lidity, in a sample of 75 young patients with GTS. The
demographic and clinical characteristics of the GTS
sample are shown in Table 1.
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Table 2
Score distributions and reliability of the C&A-GTS-QOL
Psychological Physical Obsessive-compulsive Cognitive
subscale subscale subscale subscale
Scaling assumptions
Range of item mean scores 0.7–1.4 0.4–1.4 0.5–1.3 0.7–1.4
Range of item SD 1.0–1.3 0.9–1.3 1.0–1.3 1.0–1.2
Range of corrected item-total correlations 0.5–0.7 0.3–0.5 0.3–0.7 0.3–0.6
Acceptability
Mean (SD) 11.7 (9.0) 6.1 (4.6) 4.8 (3.9) 4.1 (3.1)
Median 10.0 5. 4. 4.
Range of scores 0–42 0–22 0–17 0–1
Skewness/SE skewness 0.7/0.3 0.9/0.3 0.6/0.3 0.7/0.3
Floor/ceiling effects, % 0.3/0.5 0.8/0.5 0.0/0.5 0.0/0.5
Reliability
Internal consistency (Cronbach’s alpha) 0.9 0.7 0.7 0.7
Abbreviations. C&A-GTS-QOL = Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents.
Table 3
Principal-component factor analysis of the 27-item C&A-GTS-QOL (oblimin rotated solution; loading 0.50 are shown)
Factor 1: Factor 2: Factor 3: Factor 4:
psychological physical obsessive-compulsive cognitive
Depressed mood 0.87
Lack of control over own life 0.45
Loneliness/isolation 0.67
Lack of self-confidence 0.65
Frustration 0.59
Lack of social support 0.67
Anxiety 0.84





Difficulty in daily life activities 0.24
Involuntary swearing 0.84
Pain or incurie 0.60
Movement dyscontrol 0.40
Phonic tics 0.28
Difficulty taking part in social activities −0.04
Repeating words 0.67
Copying people 0.62





Losing important things 0.70
Difficulty finishing tasks 0.68
% of variance explained 33.99 7.96 6.79 6.34
Abbreviations. C&A-GTS-QOL = Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents.
3.1. Acceptability
For each scale, all items/response options were en-
dorsed, with only one exception (item 26: ‘Difficulty
taking part in social activities’). The frequency distri-
butions of the items were relatively symmetrical and
not unduly skewed (low floor and ceiling effects), and
item mean scores and standard deviations were similar
(Table 2). Principal-component factor analysis (oblim-
in rotated solution) of the 27 items showed no cross-
loadings, thus supporting the grouping of items into
four subscales and their summing in each subscale to
produce a total score (Table 3). The resulting four-
factor model accounted for 55.08% of the overall vari-
ance. The pattern of score distributions is presented in
Table 2.
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Table 4
Spearman correlation coefficients between C&A-GTS-QOL scores and measures of health status and psychological
well-being
Total Psychological Physical Obsessive-compulsive Cognitive
subscale subscale subscale subscale
Age 0.01 0.10 0.22 0.11 0.07
Disease duration 0.08 0.11 0.06 0.15 0.03
YGTSS
Motor tics 0.11 0.10 0.22 0.15 0.11
Vocal tics 0.25∗∗ 0.27∗∗ 0.23∗∗ 0.28∗∗ 0.02
Impairment 0.34∗∗ 0.33∗∗ 0.29∗∗ 0.31∗∗ 0.16
CY-BOCS
Obsessions 0.13 0.10 0.17 0.23∗∗ 0.13
Compulsions 0.12 0.06 0.19 0.29∗∗ 0.10
Depression (CDI) 0.65∗ 0.63∗ 0.51∗ 0.49∗ 0.51∗
Anxiety (MASC) 0.56∗ 0.53∗ 0.56∗ 0.43∗ 0.29∗∗
∗p < 0.001; ∗∗p < 0.05.
Abbreviations. C&A-GTS-QOL = Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents;
YGTSS = Yale Global Tic Severity Scale; CY-BOCS = Children’s Yale-Brown Obsessive Compulsive Scale; CDI =
Child Depression Inventory; MASC = Multidimensional Anxiety Scale for Children.
3.2. Reliability
For all subscales, corrected item-total correlations
considerably exceeded the recommended criterion of
0.4 [20] and all internal consistency reliability estimates
(Cronbach’s alpha) exceeded 0.7 (Table 2).
3.3. Validity
The content validity of the final subscales was as-
sessed by an expert panel. Internal construct validity
was supported by the moderate correlation between the
subscales (range 0.4–0.7), implying that the GTS-QOL
subscales measure related but relatively different health
constructs. Convergent and discriminant construct va-
lidity was supported by correlations with other scales
and variables that were shown to influence HR-QOL
in GTS (e.g. depression and anxiety) [10]. Table 4
shows the Spearman correlation coefficients between
the GTS-QOL subscales and measures of health status
and psychological well-being. Finally, there were no
differences between scores for men and women.
4. Discussion
HR-QOL has consistently been shown to be im-
paired in young patients with GTS. However, until re-
cently there has been no specific HR-QOL scale for
children and adolescent with GTS. Previous studies
on HR-QOL in this patient population have all used
generic HR-QOL instruments. In their study involv-
ing 59 patients with GTS (age range 8–17 years),
Storch et al. [7] administered a generic HR-QOL in-
strument, the Pediatric Quality of Life inventory and
Parent Proxy form (PedsQL) and found that the main
predictors of low HR-QOL scores were tic severity and
‘internalizing’/‘externalizing’ behavioural symptoms.
Bernard et al. [8] found that co-morbid ADHD (inat-
tentive type) and OCD were predictors of poor HR-
QOL in 56 patients with GTS aged 5–17 years, using
the TNO-AZL Children’s Quality of Life scale-Parent
Form (TACQOL-PF). Similar results were found in
another study of 57 youths with GTS (age range 8-
17 years) using the PedsQL [9]. More recently, Ed-
dy et al. [10] administered the Youth Quality of Life
Instrument-Research Version (YQL-RV) in a clinical
sample of 50 youths with GTS (age range 11–17 years)
and found that different areas of HR-QOL were af-
fected in relation to different clinical presentations of
the ‘GTS behavioural spectrum’ [3]. Although the use
of generic instruments has the advantage of allowing
comparison between different disease groups [21], it
has significant limitations in neuropsychiatric disorders
characterised by specific motor and behavioural symp-
toms. With regards to GTS, generic instruments do not
address and are unlikely to be sensitive to tics and tic-
related symptoms or their specific impacts onHR-QOL.
Consequently, the generic PedsQL, TACQOL-PF and
YQL-RV are likely to underestimate or misrepresent
the subjective perception of health problems in GTS.
This prompted the development of a disease-specific
HR-QOL scale for young patients with GTS.
This study presents the development and validation
of a disease-specific scale for the subjective assessment
of HR-QOL in young Italian patients with GTS, dis-
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tinguishing the perceived problems of children aged 6–
12 years from those of adolescents aged 13–18 years.
Following translation and linguistic adaptation of the
27-item GTS-QOL [12], we developed two different
versions of the C&A-GTS-QOL: an interview to be
administered by qualified clinicians to 6–12 year old
children and a self-administered questionnaire for ado-
lescents (13–18 years). When testing the psychometric
properties of the C&A-GTS-QOL in a large sample of
young patients with GTS, we found that our overall re-
sults were in line with previous studies. According to
C&A-GTS-QOL standardised mean scores, HR-QOL
perception was mainly affected by physical disabili-
ty [7] and OCD symptoms [10], followed by psycho-
logical problems [6,11] and cognitive difficulties. No-
tably, the four subscales of the C&A-GTS-QOL cover
all aspects that have been shown to bear an impact on
HR-QOL in GTS.
The results of our validation study suggest that the
translation and adaptation of the GTS-QOL into the
A&C-GTS-QOL is well suited for use in the Ital-
ian population of young patients with GTS. Scaling
assumptions were satisfactory and acceptability was
good. Internal consistency reliability, as measured by
Cronbach’s alpha coefficients, ranged from 0.7 for
the physical, obsessive-compulsive and cognitive sub-
scales to 0.9 for psychological subscale, suggesting
that these subscales actually measure the same con-
struct and support the construct validity. Convergent
and discriminant validity showed a sensible pattern of
correlations between other variables and clinical scales
addressing HR-QOL.
Our study has limitations. The comprehensibility of
scale items was judged by a small non-clinical sam-
ple (school population), randomly recruited in a lim-
ited area. While we were mindful to include patients
with wide phenotype variability in the evaluation of the
scale, it is likely that patients with more severe pheno-
type were over-represented in our sample, which may
not be representative of the community GTS popula-
tion. Finally, it is important to stress that the devel-
opment of the scale was based on and targeted at the
Italian population. Thus, the psychometric properties
of the C&A-GTS-QOL scale need further testing in
different clinic and community populations.
The C&A-GTS-QOL is the first disease-specific HR-
QOL scale for Italian children and adolescents with
GTS; it will provide a useful additional subjective mea-
sure complementing available objective clinical rating
scales. Moreover, the C&A-GTS-QOL is user-friendly,
takes only about 15minutes to complete and could have
useful applications as a patient-report outcome measure
in clinical trials involving young patients with GTS.
Ongoing research includes the back-translation of the
Italian version of C&A-GTS-QOL into English lan-
guage to enable the use of this new instrument in other
Countries. Future research will also allow insightful
cross-cultural comparisons of perceived HR-QOL in
young populations with GTS.
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Appendix
Sindrome di Gilles de la Tourette – Scala sulla qualita` della vita 6–12 (GTS-QOL-C&A 6–12)
Avere problemi di salute puo` interferire con la qualita` della vita di una persona in modi diversi. Questo questionario
valuta come la malattia interferisce con il tuo benessere. Per favore, traccia una croce nella casella corrispondente
alla risposta che meglio descrive l’entita` di ciascun problema. Questa lista include problemi che potresti non aver
mai avuto.
Nelle ultime 4 settimane. . . MAI RARAMENTE QUALCHE VOLTA SPESSO SEMPRE
1. Hai avuto difficolta` a controllare i tuoi movimenti?     
2. Hai avuto difficolta` a compiere le attivita` scolastiche o
sportive che preferisci?
    
3. Hai avuto dolore o ti sei fatto male per i tuoi tic?     
4. Sei stato disturbato da rumori che non riuscivi a smettere di
fare?
    
5. Ti sei preoccupato per aver detto brutte parole senza volere?     
6. Ti sei preoccupato per aver fatto gesti volgari senza volerlo?     
7. Ti e` capitato di ripetere alcune parole piu` e piu` volte?     
8. Hai dovuto ripetere parole o gesti di altre persone senza
volere?
    
9. Hai dovuto ripetere alcune cose piu` e piu` volte nello stesso
modo (es. controllare, toccare)?
    
10. Ti e` capitato di avere brutti pensieri o brutte immagini nella
tua mente ?
    
11. Hai avuto difficolta` di concentrazione?     
12. Hai avuto problemi di memoria?     
13. Hai perso o messo fuori posto cose importanti (es. libri,
quaderni, chiavi, cellulare)?
    
14. Hai avuto difficolta` a finire un compito una volta iniziato?     
15. Ti sei sentito male?     
16. Sei stato triste o depresso?     
17. Ti e` capitato di diventare improvvisamente triste o
improvvisamente allegro senza motivo?
    
18. Hai smesso di fare qualcosa perche´ pensavi di non riuscirci?     
19. Ti sei sentito scontento?     
20. Ti sei sentito agitato?     
21. Hai avuto difficolta` a controllare la tua rabbia?     
22. Ti sei sentito come se non fossi in grado di controllare cio`
che fai?
    
23. Ti sei arrabbiato quando non sei riuscito a fare qualcosa?     
24. Hai sentito il bisogno di maggiore aiuto o incoraggiamento
da parte di altre persone?
    
25. Hai avuto difficolta` a stare insieme ai tuoi amici?     
26. Hai avuto difficolta` nelle uscite fuori casa con gli altri (es.
cinema, feste)?
    
27. Ti sei sentito solo o isolato?     
Per favore, indica quanto ti senti contento della tua vita in questo momento mettendo una croce sulla linea da 0 a
100:
Grazie per aver compilato questo questionario!
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Sindrome di Gilles de la Tourette – Scala sulla qualita` della vita 13–18 (GTS-QOL-C&A 13–18)
Avere problemi di salute puo` interferire con la qualita` della vita di una persona in modi diversi. Questo questionario
valuta come la malattia interferisce con il tuo benessere. Per favore, traccia una croce nella casella corrispondente
alla risposta che meglio descrive l’entita` di ciascun problema. Questa lista include problemi che potresti non aver
mai avuto.
Nelle ultime 4 settimane . . . MAI RARAMENTE QUANCHE VOLTA SPESSO SEMPRE
1. Hai avuto difficolta` a controllare i tuoi movimenti?     
2. Hai avuto difficolta` nello svolgimento delle attivita` quotidi-
ane o degli svaghi che preferisci (cucinare, scrivere)?
    
3. Hai avuto dolore o danni fisici conseguenti ai tuoi tic?     
4. Hai avuto problemi dovuti a rumori che non riuscivi a
smettere di fare?
    
5. Ti sei preoccupato per aver usato parolacce che in realta` non
volevi dire?
    
6. Ti sei preoccupato per aver fatto gesti imbarazzanti (es. gesti
volgari)?
    
7. Hai dovuto ripetere alcune parole molte volte?     
8. Hai dovuto ripetere cose che altre persone hanno detto o
fatto (es. imitare persone)?
    
9. Hai dovuto ripetere alcune azioni piu` e piu` volte nello stesso
modo (es. controllare, toccare)?
    
10. Hai avuto pensieri spiacevoli o immagini che si insinuavano
nella tua mente?
    
11. Hai avuto difficolta` di concentrazione?     
12. Hai avuto problemi di memoria?     
13. Hai perso o messo fuori posto cose importanti (es. chiavi,
cellulare)?
    
14. Hai rinunciato a finire un compito una volta iniziato?     
15. Non ti sei sentito in forma?     
16. Sei stato triste o depresso?     
17. Ti e` capitato di passare rapidamente dall’essere allegro
all’essere triste?
    
18. Hai avuto mancanza di fiducia in te stesso?     
19. Ti sei sentito ansioso?     
20. Ti sei sentito agitato?     
21. Hai avuto difficolta` a controllare la tua collera?     
22. Ti sei sentito come se non avessi il controllo della tua vita?     
23. Ti sei sentito frustrato?     
24. Hai sentito la necessita` di un maggiore aiuto o supporto da
parte di altre persone?
    
25. Hai avuto difficolta` a frequentare i tuoi amici?     
26. Hai avuto difficolta` a prendere parte ad attivita` sociali (es.
mangiare fuori)?
    
27. Ti sei sentito solo o isolato?     
Per favore, indica quanto ti senti soddisfatto della tua vita in questo momento mettendo una croce sulla linea da 0
a 100:
Grazie per aver compilato questo questionario!
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